Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for virology and immunology indications. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the ...
Leadership
Jay R. Luly Ph.D.
President, CEO & Director
Yat Sun Or Ph.D.
Chief Scientific Officer
Scott T. Rottinghaus M.D.
Chief Medical Officer
Harry R. Trout III
VP of Finance & Interim Principal Financial Officer
Kathleen S. Capps CPA
Executive Director of Accounting, Controller & Interim Principal Accounting Officer
Jennifer Viera
Executive Director of Investor Relations & Corporate Communications
